UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008263
Receipt number R000009739
Scientific Title Expression of inflammatory signaling molecules in food protein-induced enterocolitis syndrome and rectal bleeding in infancy.
Date of disclosure of the study information 2012/07/01
Last modified on 2014/06/27 12:37:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Expression of inflammatory signaling molecules in food protein-induced enterocolitis syndrome and rectal bleeding in infancy.

Acronym

Analysis of signaling molecules in rectal bleeding in infancy.

Scientific Title

Expression of inflammatory signaling molecules in food protein-induced enterocolitis syndrome and rectal bleeding in infancy.

Scientific Title:Acronym

Analysis of signaling molecules in rectal bleeding in infancy.

Region

Japan


Condition

Condition

Infants with rectal bleeding

Classification by specialty

Gastroenterology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the pathogenesis of rectal bleeding in infancy.

Basic objectives2

Others

Basic objectives -Others

To examine the mechanisms of rectal bleeding in infancy.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

To examined the expression of signaling molecules in rectal bleeding in infancy.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 months-old <=

Age-upper limit

12 months-old >

Gender

Male and Female

Key inclusion criteria

Infants with rectal bleeding.

Key exclusion criteria

Infants needing for surgical treatment.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshikazu Ohtsuka

Organization

Juntendo University Graduate School of Medicine

Division name

Department of Pediatrics and Adolescent Medicine

Zip code


Address

3-1-3, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

TEL

03-3813-3111

Email

yohtsuka@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshikazu Ohtsuka

Organization

Juntendo University Graduate School of Medicine

Division name

Department of Pediatrics and Adolescent Medicine

Zip code


Address

3-1-3, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

TEL

03-3813-3111

Homepage URL


Email

yohtsuka@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂医院(東京都)


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 06 Month 22 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Inflammatory signaling molecules with rectal bleeding in infancy.


Management information

Registered date

2012 Year 06 Month 26 Day

Last modified on

2014 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009739


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name